(Q36252844)

13 August 2017

1 reference

title

Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I. (English)

1 reference

13 August 2017

M Sarter

1

1 reference

PubMed ID

1615119

13 August 2017

J Hagan

series ordinal

2

1 reference

PubMed ID

1615119

13 August 2017

P Dudchenko

series ordinal

3

1 reference

13 August 2017

1 January 1992

1 reference

13 August 2017

1 reference

13 August 2017

107

1 reference

13 August 2017

144-159

1 reference

13 August 2017

2-3

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02245132

13 August 2017

0 references

cites work

Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86.

1 reference

https://api.crossref.org/works/10.1007%2FBF02245132

Nootropic drugs in Alzheimer's disease: symptomatic treatment with pramiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245132

Induction of depression with oxotremorine in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245132

A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245132

Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245132

Failure of cholinergic agonist RS-86 to improve cognition and movement in PSP despite effects on sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245132

Animal model of depression. I. Review of evidence: implications for research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245132

Clonidine treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245132

Disinhibitory properties of beta-carboline antagonists of benzodiazepine receptors: a possible therapeutic approach for senile dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245132

Effect of V-9-M, a peptide fragment derived from procholecystokinin, on memory processes in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245132

Multiple-dose arecoline infusions in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245132

DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245132

Pharmacological approaches in the treatment of senile dementia

21 January 2018

1 reference

12 December 2020

Piracetam combined with lecithin in the treatment of Alzheimer's disease.

1 reference

12 December 2020

Enhancement of learning and memory in mice by a benzodiazepine antagonist

1 reference

12 December 2020

The cholinergic hypothesis--ten years on.

1 reference

12 December 2020

Attenuation of experimentally-induced amnesia

1 reference

12 December 2020

Tetrahydroaminoacridine improves the spatial acquisition deficit produced by nucleus basalis lesions in rats

1 reference

12 December 2020

Effects of the novel compound, Hoe 065, upon impaired learning and memory in rodents

1 reference

12 December 2020

Intracerebroventricular bethanechol chloride infusion in Alzheimer's disease. Results of a collaborative double-blind study.

1 reference

12 December 2020

Effects of different doses of galanthamine, a long-acting acetylcholinesterase inhibitor, on memory in mice.

1 reference

12 December 2020

Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia

1 reference

12 December 2020

Effects of DM-9384, a pyrrolidone derivative, on alcohol- and chlordiazepoxide-induced amnesia in mice

1 reference

12 December 2020

Enhancing effects of Hoe 175 on memory in mice

1 reference

12 December 2020

Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine

1 reference

12 December 2020

Dissociating learning and performance: drug and hormone enhancement of memory storage

1 reference

12 December 2020

Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine

1 reference

12 December 2020

The retroactive effect of electroshock on learning.

1 reference

12 December 2020

Visuospatial learning impairment following lesion of the cholinergic projection to the hippocampus

1 reference

12 December 2020

Effects of the novel compound NIK-247 on impairment of passive avoidance response in mice.

1 reference

12 December 2020

Memory facilitating and anti-amnesic effects of corticosteroids

1 reference

12 December 2020

Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.

1 reference

12 December 2020

The silent epidemic: the search for treatment of age-related memory impairment

1 reference

12 December 2020

Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients

1 reference

12 December 2020

Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.

1 reference

12 December 2020

Different forms of post-training memory processing

1 reference

12 December 2020

Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia

1 reference

12 December 2020

Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces

1 reference

12 December 2020

Bidirectional effects of beta-carbolines and benzodiazepines on cognitive processes.

1 reference

12 December 2020

Effect of cholinesterase inhibitors on Morris water task behavior following lesions of the nucleus basalis magnocellularis.

1 reference

12 December 2020

1 reference

12 December 2020

Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics.

1 reference

12 December 2020

Effects of a new TRH analogue, YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents.

1 reference

12 December 2020

TRH attenuates scopolamine-induced memory impairment in humans

1 reference

12 December 2020

Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia

1 reference

12 December 2020

Attenuation of scopolamine-induced amnesia in mice

1 reference

12 December 2020

Treatment of alcohol organic mental disorder with piracetam.

1 reference

12 December 2020

Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot study

1 reference

12 December 2020

Pharmacological alleviation of cholinergic lesion induced memory deficits in rats

1 reference

12 December 2020

Drugs as Research Tools in Psychology: Cholinergic Drugs and Information Processing

1 reference

12 December 2020

The validity of animal models of depression

1 reference

12 December 2020

A long-acting cholinesterase inhibitor reverses spatial memory deficits in mice.

1 reference

12 December 2020

Animal memory and learning

1 reference

12 December 2020

Scopolamine interactions with D1 and D2 antagonists on radial-arm maze performance in rats

1 reference

12 December 2020

Intravenous nicotine in Alzheimer's disease: a pilot study.

1 reference

12 December 2020

Lack of efficacy of hydergine in patients with Alzheimer's disease

1 reference

12 December 2020

Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats.

1 reference

12 December 2020

Brain cyclic AMP and memory in mice

1 reference

12 December 2020

Central muscarinic activities of an M1-selective agonist: preferential effect on reversal of amnesia

1 reference

12 December 2020

Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents

1 reference

12 December 2020

Cholinomimetic treatment fails to improve memory disorders.

1 reference

12 December 2020

Effects of DM-9384 in a model of amnesia based on animals with GABAergic neuronal dysfunctions

1 reference

12 December 2020

Effects of cholinergic drugs on learning impairment in ventral globus pallidus-lesioned rats.

1 reference

12 December 2020

Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines

1 reference

12 December 2020

Chronic stress and memory: implication of the central cholinergic system

1 reference

12 December 2020

Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT)

1 reference

12 December 2020

Effects of ibotenic acid lesions of the basal forebrain on serial reversal learning in marmosets.

1 reference

12 December 2020

A critique of the vasopressin-memory hypothesis

1 reference

12 December 2020

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

1 reference

12 December 2020

Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.

1 reference

12 December 2020

Spontaneous exploration of a 6-arm radial tunnel maze by basal forebrain lesioned rats: effects of the benzodiazepine receptor antagonist beta-carboline ZK 93 426.

1 reference

12 December 2020

Quantitative histochemistry of brain acetylcholinesterase and learning rate in the aged rat.

1 reference

12 December 2020

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

12 December 2020

Cerebral Protein Synthesis Inhibitors Block Long-Term Memory

1 reference

12 December 2020

Retrograde Amnesia: Temporal Gradient in Very Long Term Memory Following Electroconvulsive Therapy

1 reference

12 December 2020

Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study

1 reference

12 December 2020

(+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity

1 reference

12 December 2020

The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates

1 reference

12 December 2020

Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine

1 reference

12 December 2020

Behavioral methods for measuring effects of drugs on learning and memory in animals

1 reference

12 December 2020

Multicenter trial of naloxone in Alzheimer's disease.

1 reference

12 December 2020

Tetrahydroaminoacridine (THA) in Alzheimer's disease

1 reference

12 December 2020

Attenuation of benzodiazepine-induced passive avoidance deficit by post-training administration of muscimol: interaction with the cholinergic neuronal system.

1 reference

12 December 2020

Bidirectional nature of benzodiazepine receptor ligands extends to effects on vigilance.

1 reference

12 December 2020

GABAergic modulation of memory with regard to passive avoidance and conditioned suppression task in mice.

1 reference

12 December 2020

Effects of arecoline and pilocarpine on learning ability in marmosets pretreated with hemicholinium-3.

1 reference

12 December 2020

Drug Effects and Learning and Memory Processes

1 reference

12 December 2020

The need for common perspectives in the development and use of animal models for age-related cognitive and neurodegenerative disorders

1 reference

12 December 2020

Behavioral effects of nimodipine in animals.

1 reference

12 December 2020

Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in Alzheimer's presenile dementia.

1 reference

12 December 2020

Learning impairment following lesion of the basal nucleus of Meynert in the marmoset: modification by cholinergic drugs

1 reference

12 December 2020

Failure of chronic physostigmine to ameliorate working memory deficits after medial septal lesions.

1 reference

12 December 2020

Elevation of brain tyrosine by inhibitors of protein synthesis is not responsible for their amnesic effect

1 reference

12 December 2020

Tetrahydroaminoacridine facilitates passive avoidance learning in rats with nucleus basalis magnocellularis lesions.

1 reference

12 December 2020

Alzheimer's disease. Arresting memory decline.

1 reference

12 December 2020

The role of cholinergic projections from the nucleus basalis in memory

1 reference

12 December 2020

Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment

1 reference

12 December 2020

Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions

1 reference

12 December 2020

Memory retrieval deficits: alleviation by etiracetam, a nootropic drug

1 reference

12 December 2020

Oxiracetam prevents mecamylamine-induced impairment of active, but not passive, avoidance learning in mice

1 reference

12 December 2020

Animal models of Alzheimer's disease: behavior, pharmacology, transplants.

1 reference

12 December 2020

Effects of cycloheximide, a protein synthesis inhibitor, on mouse brain catecholamine biochemistry.

1 reference

12 December 2020

Frontal cortex as the site of action of physostigmine in nbM-lesioned rats

1 reference

12 December 2020

1 reference

12 December 2020

Cholinergic function and intellectual decline in Alzheimer's disease

1 reference

12 December 2020

Effects of aniracetam on delayed matching-to-sample performance of monkeys and pigeons.

1 reference

12 December 2020

Nucleus basalis magnocellularis lesions: lack of biochemical and immunocytochemical recovery and effect of cholinesterase inhibitors on passive avoidance.

1 reference

12 December 2020

4-Aminopyridine in the treatment of Alzheimer's disease.

1 reference

12 December 2020

Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine

1 reference

12 December 2020

Reversal of scopolamine-induced amnesia of passive avoidance by pre- and post-training naloxone

1 reference

12 December 2020

Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome

1 reference

12 December 2020

The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type

1 reference

12 December 2020

Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case

1 reference

12 December 2020

Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification

1 reference

12 December 2020

(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats.

1 reference

12 December 2020

Involvement of hormonal and neuromodulatory systems in the regulation of memory storage

1 reference

12 December 2020

Effect of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (MCI-2016) on the scopolamine-induced deficit of spontaneous alternation behavior in rats.

1 reference

12 December 2020

The effects of THA on medial septal lesion-induced memory defects.

1 reference

12 December 2020

Therapeutic effect of THA on hemicholinium-3-induced learning impairment is independent of serotonergic and noradrenergic systems.

1 reference

12 December 2020

Effects of DM-9384, a cyclic derivative of GABA, on amnesia and decreases in GABAA and muscarinic receptors induced by cycloheximide

1 reference

12 December 2020

Low dose tetrahydroaminoacridine (THA) improves cognitive function but does not affect brain acetylcholine in rats.

1 reference

12 December 2020

Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed.

1 reference

12 December 2020

Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats

1 reference

12 December 2020

Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic rodents.

1 reference

12 December 2020

Scopolamine effects on memory retention in mice: a model of dementia?

1 reference

12 December 2020

Interactions of scopolamine and physostigmine with ECS and one trial learning

1 reference

12 December 2020

Topographical distribution of neurochemical changes in Alzheimer's disease

1 reference

12 December 2020

RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects.

1 reference

12 December 2020

Parallel modifications of spatial memory performances, exploration patterns, and hippocampal theta rhythms in fornix-damaged rats: reversal by oxotremorine

1 reference

12 December 2020

Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects

1 reference

12 December 2020

Cholinergic—dopaminergic interactions in radial-arm maze performance

1 reference

12 December 2020

Progress report on the Canadian Multicentre Trial of tetrahydroaminoacridine with lecithin in Alzheimer's disease

1 reference

12 December 2020

Radial-arm maze deficits produced by colchicine administered into the area of the nucleus basalis are ameliorated by cholinergic agents

1 reference

12 December 2020

Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats.

1 reference

12 December 2020

No response to high-dose muscarinic agonist therapy in Alzheimer's disease

1 reference

12 December 2020

Effect of a novel CNS-selective cholinesterase inhibitor, SM-10888, on habituation and passive avoidance responses in mice.

1 reference

12 December 2020

Antibiotics and memory

1 reference

12 December 2020

Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats

1 reference

12 December 2020

Acute effects of oral pyridostigmine on memory and cognitive function in SDAT.

1 reference

12 December 2020

Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats.

1 reference

12 December 2020

Human studies on the benzodiazepine receptor antagonist beta-carboline ZK 93,426: preliminary observations on psychotropic activity

1 reference

12 December 2020

Beneficial effects of FKS-508 (AF102B), a selective M1 agonist, on the impaired working memory in AF64A-treated rats.

1 reference

12 December 2020

Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats

1 reference

12 December 2020

Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nucleus basalis magnocellularis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245132

1 reference

13 August 2017

1 reference

PubMed ID

1615119